Nureca Limited
NSE:NURECA.NS
334.6 (INR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 202.69 | 169.7 | 223.74 | 313.53 | 212.31 | 212.26 | 277.88 | 367.81 | 255.28 | 410.49 | 480.77 | 469.4 | 1,194.82 | 318.4 | 594.69 | 919.28 | 302.17 | 329.6 |
| Cost of Revenue
| 164.55 | 111.81 | 158.79 | 191.34 | 144.21 | 143.21 | 167.13 | 274.16 | 170.81 | 258.79 | 292.53 | 280.49 | 494.43 | 164.48 | 328.34 | 382.16 | 96.74 | 224.04 |
| Gross Profit
| 38.14 | 57.89 | 64.95 | 122.19 | 68.1 | 69.05 | 110.75 | 93.65 | 84.47 | 151.7 | 188.24 | 188.91 | 700.39 | 153.92 | 266.35 | 537.12 | 205.43 | 105.56 |
| Gross Profit Ratio
| 0.188 | 0.341 | 0.29 | 0.39 | 0.321 | 0.325 | 0.399 | 0.255 | 0.331 | 0.37 | 0.392 | 0.402 | 0.586 | 0.483 | 0.448 | 0.584 | 0.68 | 0.32 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | -9.59 | 0 | 0 | 0 | 39.73 | 0 | 0 | 0 | 37.17 | 0 | 0 | 0 | 41.88 | 18.535 | 6.31 | 5.37 | 0 |
| Selling & Marketing Expenses
| 0 | 40.27 | 0 | 0 | 0 | 35.98 | 0 | 0 | 0 | 117.38 | 0 | 0 | 0 | 47.94 | 47.94 | 17.6 | 2.53 | 0 |
| SG&A
| 68.39 | 30.68 | 74.71 | 77.69 | 27.89 | 75.71 | 80.04 | 92.7 | 42.79 | 154.55 | 20.32 | 22.91 | 204.31 | 89.82 | 66.475 | 23.91 | 7.9 | 8.57 |
| Other Expenses
| 57.94 | -12.59 | 59.01 | 31.99 | 26.73 | 21.48 | 18.96 | 18.9 | 11.71 | -57.33 | 17.36 | 21.1 | 21.39 | -14.4 | 7.1 | 6.64 | 1.64 | 0 |
| Operating Expenses
| 68.39 | 108.23 | 113.41 | 114.22 | 102.96 | 109.22 | 125.92 | 148.92 | 147.83 | 177.22 | 141.27 | 131.69 | 231.01 | 99.97 | 165.08 | 176.09 | 76.46 | 69.44 |
| Operating Income
| -30.25 | -62.93 | 10.55 | 39.96 | -34.86 | -18.69 | 3.79 | -36.37 | -63.36 | -33.3 | 46.97 | 57.22 | 469.38 | 54.56 | 85.27 | 368.19 | 128.97 | 35.65 |
| Operating Income Ratio
| -0.149 | -0.371 | 0.047 | 0.127 | -0.164 | -0.088 | 0.014 | -0.099 | -0.248 | -0.081 | 0.098 | 0.122 | 0.393 | 0.171 | 0.143 | 0.401 | 0.427 | 0.108 |
| Total Other Income Expenses Net
| 56.44 | -1.79 | -1.1 | -0.84 | 25.57 | -1.04 | -1.09 | -1.02 | 10.36 | 14.25 | 16.23 | 19.86 | 19.2 | -2.57 | -0.38 | -8.74 | -1.97 | -3.37 |
| Income Before Tax
| 26.19 | -64.72 | 9.45 | 39.12 | -9.29 | -19.73 | 2.7 | -37.39 | -53 | -19.05 | 63.2 | 77.08 | 488.58 | 51.99 | 84.89 | 359.45 | 127 | 32.28 |
| Income Before Tax Ratio
| 0.129 | -0.381 | 0.042 | 0.125 | -0.044 | -0.093 | 0.01 | -0.102 | -0.208 | -0.046 | 0.131 | 0.164 | 0.409 | 0.163 | 0.143 | 0.391 | 0.42 | 0.098 |
| Income Tax Expense
| 9.57 | -23.26 | 7.8 | 10.18 | -2.22 | -4.43 | -0.31 | -8.47 | -11.71 | -5.11 | 15.86 | 22.74 | 126.62 | 13.08 | 21.86 | 92.12 | 32.53 | 8.46 |
| Net Income
| 16.62 | -41.46 | 1.65 | 28.94 | -7.07 | -15.3 | 3.01 | -28.92 | -41.29 | -13.94 | 47.34 | 54.34 | 361.96 | 38.91 | 63.03 | 267.33 | 94.47 | 23.82 |
| Net Income Ratio
| 0.082 | -0.244 | 0.007 | 0.092 | -0.033 | -0.072 | 0.011 | -0.079 | -0.162 | -0.034 | 0.098 | 0.116 | 0.303 | 0.122 | 0.106 | 0.291 | 0.313 | 0.072 |
| EPS
| 1.66 | -4.15 | 0.17 | 2.89 | -0.71 | -1.53 | 0.3 | -2.89 | -4.13 | -1.39 | 4.73 | 5.43 | 36.2 | 4.56 | 8.51 | 36.09 | 13.5 | 3.4 |
| EPS Diluted
| 1.66 | -4.15 | 0.17 | 2.89 | -0.71 | -1.53 | 0.3 | -2.89 | -4.13 | -1.39 | 4.73 | 5.43 | 36.2 | 4.56 | 8.51 | 36.09 | 13.5 | 3.4 |
| EBITDA
| -23.69 | -56.93 | 16.46 | 45.84 | -2.3 | -13.08 | 9.8 | -30.18 | -45.58 | -13.33 | 68.56 | 81.44 | 492.32 | 55.24 | 87.03 | 368.53 | 131.53 | 35.843 |
| EBITDA Ratio
| -0.117 | -0.335 | 0.074 | 0.146 | -0.011 | -0.062 | 0.035 | -0.082 | -0.179 | -0.032 | 0.143 | 0.173 | 0.412 | 0.173 | 0.146 | 0.401 | 0.435 | 0.109 |